ABSTRACT
Abstract Background Bursectomy consists of surgically removing the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon during gastrectomy. However, there are little data to indicate whether bursectomy has a clinical benefit. Objective The objective of this study was to study the effect of bursectomy on complications, recurrence, and overall survival of patients with gastric cancer. Methods The publicly available literature published from January 2000 to July 2017 concerning gastrectomy with bursectomy and standard gastrectomy for gastric cancer was retrieved by searching the national and international online databases. Meta-analysis was performed after the data extraction process. Results Eight studies were finally included for a total of 1644 patients, of whom 644 underwent bursectomy and 1000 received standard gastrectomy without bursectomy. As shown by the meta-analysis results, there were no statistically significant differences in the presence of total post-operative complications (odds ratio [OR] = 1.06, 95% confidence interval [CI] [0.83-1.35], p = 0.63), overall recurrence (OR = 1.07, 95% CI [0.77-1.50], p = 0.68), 3-year overall survival (OR = 1.30, 95% CI [0.82-2.07], p = 0.26), and 5-year overall survival (OR = 0.91, 95% CI [0.66-1.27], p = 0.58). Conclusion Although application of bursectomy in radical gastrectomy did not increase post-operative complications, it offered no benefit to control tumor recurrence or improve overall survival.
Subject(s)
Humans , Postoperative Complications/epidemiology , Stomach Neoplasms/surgery , Gastrectomy/methods , Randomized Controlled Trials as Topic , Treatment Outcome , Gastrectomy/adverse effectsABSTRACT
Resumen Introducción: La resección quirúrgica ha demostrado ser la única opción curativa para el cáncer gástrico, al incluir linfadenectomía D2 como estándar de seguridad. Sin embargo, el beneficio de extender la resección a la bursa omentalis sigue siendo controvertido. La investigación publicada no ha arrojado evidencia categórica definiendo la eficacia. Realizamos una revisión sistemática de ensayos clínicos aleatorizados publicados (ECA), para evaluar el beneficio de la bursectomía en la sobrevida global (OS) y la sobrevida libre de enfermedad (SLE) de los pacientes. Como resultado secundario se consideró la seguridad del procedimiento. Métodos: Se realizó una búsqueda bibliográfica en las bases de datos de Pubmed, Cochrane, Scielo, Metabuscador PUC, Epistemonikos, Tripdatabase, Sciencedirect y Lilacs para ECA que compararan la bursectomía con la no bursectomía, publicados antes de marzo de 2016. Se establecieron y aplicaron criterios de inclusión y exclusión. Resultados: Se encontraron 3 ECA correspondientes a diferentes informes de la misma cohorte de pacientes. Se incluyeron 210 pacientes (104 en el grupo de bursectomía y 106 en el grupo de no bursectomía). La bursectomía no tuvo un efecto significativo ni en la OS a 5 años (HR: 1,4; IC del 95%: 0,87-2,25) ni en la SLE (HR: 1,25; IC del 95% 0,80-1,97). No se observó diferencia estadísticamente significativa en la tasa de complicaciones al comparar el grupo de bursectomía y el grupo de no bursectomía. Conclusión: La gastrectomía con bursectomía no es superior a la no bursectomía, ya sea en términos de OS a 5 años o de SLE.
Abstract Introduction: The surgical resection has proved to be the only curative option for Gastric Cancer, when including D2 linfadenectomy as security standard. The benefit of extending the resection to the bursa omentalis, however, is still controversial. The published research has not yielded categorical evidence on defining the efficacy of bursectomy. We conducted a systematic review of published randomized controlled trials (RCT), to evaluate the benefit of bursectomy in the overall survival (OS) and disease-free survival (DFS) of patients. As secondary outcome, was considered the safety of the procedure. Methods: A literature search was conducted in Pubmed, Cochrane library databases, Scielo, Metabuscador PUC, Epistemonikos, Tripdatabase, Sciencedirect, and Lilacs for randomized clinical trials comparing bursectomy with non-bursectomy, published before March 2016. Inclusion and exclusion criteria were established and applied. Results: We found three RCT corresponding to different reports of the same cohort of randomized patients. They included 210 patients (104 in the bursectomy group, and 106 in the non-bursectomy group). The bursectomy did not have a significant effect either on 5-years OS (HR: 1.4; 95%CI: 0,87-2,25), or on DFS (HR: 1.25; 95% CI: 0,80-1,97). No statistically significant difference was observed in the rate of complications, when comparing the bursectomy group and the non-bursectomy group. Conclusion: Gastrectomy with bursectomy is not superior to non-bursectomy either in terms of 5 years OS or on DFS.
Subject(s)
Humans , Stomach Neoplasms/surgery , Gastrectomy/methods , Peritoneal Cavity/surgery , Postoperative Complications , Stomach Neoplasms/mortality , Survival Analysis , Disease-Free SurvivalABSTRACT
There is controversy about the usefulness of bursectomy and omentectomy during the surgical treatment of gastric cancer. Bursectomy, a procedure dissecting the peritoneal lining covering the pancreas and the anterior plane of the transverse mesocolon, is a major surgical aggression. There is no evidence that the procedure improves five years survival. It may be useful in serosal gastric cancer of the posterior wall. Excision or resection of all or part of an omentum does not have either an effect on survival. However, we recommend its use since its lack of benefit has not been completely ascertained.
Dentro de las etapas quirúrgicas de la gastrectomía por cáncer gástrico, existen controversias respecto a la bursectomía y la omentectomía. La bursectomía (resección de peritoneo que cubre la porción anterior del mesocolon transverso y la cápsula pancreática) representa una mayor agresión quirúrgica, sin evidencia actual de que aumenta la sobrevida a 5 años, ello evaluado en 3 estudios clínicos. Su utilidad parece estar en pacientes con cáncer gástrico seroso de la cara posterior. La omentectomía total, comparada con la omentectomía parcial, ha sido evaluada más extensamente, sin poder demostrar hasta la actualidad la superioridad de uno u otro procedimiento en cuanto a sobrevida a 5 años. Sin embargo, mientras no se demuestre claramente lo opuesto en estudios científicos, recomendamos realizarla rutinariamente.
Subject(s)
Humans , Gastrectomy/methods , Stomach Neoplasms/surgeryABSTRACT
Multiple rice body formation is a complication of chronic bursitis frequently associated with seronegative rheumatoid arthritis or tuberculosis. It resembles synovial chondromatosis on imaging and clinically. We report on a pathologically diagnosed multiple rice body formation in subacromial and subdeltoid bursitis in a 44-year-old man who was treated by surgical removal and bursectomy. At 16 months after the removal, range of motion of affected shoulder was normal. No evidence of recurrence of rice body in plain X-ray and ultrasonography. Multiple rice body formed in chronic subacromial and subdeltoid bursitis could be treated with surgical removal and bursectomy successfully.
Subject(s)
Adult , Humans , Arthritis, Rheumatoid , Bursitis , Chondromatosis, Synovial , Range of Motion, Articular , Recurrence , Shoulder , Tuberculosis , UltrasonographyABSTRACT
PURPOSE: To compare the result of endoscopic versus open bursectomy in lateral malleolar bursitis, which was not treated conservatively. MATERIALS AND METHODS: Between January 2008 and October 2009, We divided to two groups, endoscopy (group A) 11 cases, open bursectomy (group B) 11 cases. The average follow up period was 15 months (range, 12 to 18), the mean age was 66 (range, 38 to 79). We compared patients satisfaction, complete healing time, operation time, complications and recurrence. RESULTS: Group A had significant difference in terms of the clinical satisfactions, complete healing time. operation time, complications. Group A showed satisfaction (excellent 9, good 2), mean complete healing time 11.9 (8~14) days, operation time 37 (25~45) minutes, 1 case recur. Group B showed satisfaction (excellent 4, good 3, fair 1, poor 3), complete healing time 32.7 (14~98) days, operation time 22 (18~26) minutes. complication were one case of skin necrosis, one case of wound dehiscence, two cases of superficial peroneal nerve injury, no recurrence. Significant advantages of endoscopic method include lower morbidity and rapid wound healing period (p<0.05). CONCLUSION: Endoscopic resection of the lateral malleolar bursitis is a promising technique and shows favourable results compared to the open resection. Significant advantages of this method include lower morbidiy and rapid wound healing.
Subject(s)
Animals , Humans , Ankle , Bursitis , Endoscopy , Follow-Up Studies , Necrosis , Peroneal Nerve , Recurrence , Skin , Wound HealingABSTRACT
Ischiogluteal bursitis is a cause of buttock pain. Patients, who have ischiogluteal bursitis, usually have painful swelling over the center of the buttock and down the back of the leg. Ischiogluteal bursitis is frequently confused with many other causes of lower extremity buttock pain because of its anatomical characteristics. Generally, conservative treatment for ischiogloteal bursitis is usually sufficient. However, some severe cases with chronic painful ischiogluteal bursitis necessitates surgical treatment. Few reports describe the surgical treatment for this condition. The authors report 3 cases of chronic ischiogluteal bursitis who were successfully treated with surgical bursectomy.